Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
5 clinical trials · Condition
◉ Watch Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer (NCT03468218) | Emory University | 2018-09-18 |
| ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment (NCT02917629) | National Cancer Institute (NCI) | 2018-05-31 |
| Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma (NCT02775812) | National Cancer Institute (NCI) | 2016-11-28 |
| Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin (NCT02381535) | National Cancer Institute (NCI) | 2015-10-22 |
| Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (NCT01064479) | M.D. Anderson Cancer Center | 2010-02-05 |
Track Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 automatically
Every clearance here is in the API, with alerts when new ones post.